Title:
【発明の名称】IDDMの治療法
Document Type and Number:
Japanese Patent JPH06510061
Kind Code:
A
Abstract:
Insulin dependent diabetes mellitus is treated by administering to a patient during preclinical or early onset stages of the disease a therapeutically effective dose of an alpha interferon antagonist. Suitable antagonist include anti-alpha interferon neutralizing antibodies, neutralizing antibodies directed against the alpha interferon receptor polypeptides, soluble preparations of the alpha interferon receptor, alpha interferon fragments and the like.
Inventors:
Stewart, Timothy Andrew
Application Number:
JP50523493A
Publication Date:
November 10, 1994
Filing Date:
August 19, 1992
Export Citation:
Assignee:
Genentech, Inc.
International Classes:
A61K39/395; A61P3/08; A61K38/00; A61P3/10; C07K14/56; C07K14/715; C07K16/24; C07K16/28; (IPC1-7): A61K39/395; A61K37/02
Attorney, Agent or Firm:
Aoyama Ryo (2 outside people)